Overview Financials News + Filings Key Docs Ownership
|
|
RedHill Biopharma Ltd. (RDHL)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
| Revenues |
| |
| Adjusted EBITDA |
| Commercial Operations | -15.5 | -27.2 | -15.9 | | | | | |
| Research and Development | -37.2 | -23.5 | -23.0 | | | | | |
| |
| EBIT |
| |
| Mix |
| |
| Growth |
|